Charles Peloquin

Charles Peloquin

University of Florida

H-index: 75

North America-United States

About Charles Peloquin

Charles Peloquin, With an exceptional h-index of 75 and a recent h-index of 43 (since 2020), a distinguished researcher at University of Florida, specializes in the field of tuberculosis, pharmacokinetics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Cefepime pharmacokinetics in adult extracorporeal membrane oxygenation patients

Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics

Role of therapeutic drug monitoring in the treatment of multi-drug resistant tuberculosis

Isoniazid urine spectrophotometry for prediction of serum pharmacokinetics in adults with TB

VIGAB-STAT—A Phase IIa Feasibility Trial of Irreversible GABA-transaminase Inhibition as Adjunct Treatment of Status Epilepticus After Cardiac Arrest (P4-2.003)

Association of piperacillin and vancomycin exposure on acute kidney injury during combination therapy

Dynamic PET Reveals Compartmentalized Brain and Lung Tissue Antibiotic Exposures

Linezolid does not improve bactericidal activity of rifampin-containing first-line regimens in animal models of TB meningitis

Charles Peloquin Information

University

Position

Professor of Pharmacy

Citations(all)

20949

Citations(since 2020)

7969

Cited By

16341

hIndex(all)

75

hIndex(since 2020)

43

i10Index(all)

261

i10Index(since 2020)

167

Email

University Profile Page

University of Florida

Google Scholar

View Google Scholar Profile

Charles Peloquin Skills & Research Interests

tuberculosis

pharmacokinetics

Top articles of Charles Peloquin

Title

Journal

Author(s)

Publication Date

Cefepime pharmacokinetics in adult extracorporeal membrane oxygenation patients

Pulmonary Pharmacology & Therapeutics

Lily Zheng

Mohammad H Alshaer

Charles Peloquin

Veena Venugopalan

Hassan M Alnuaimat

...

2024/3/1

Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics

Nicole F Maranchick

Awewura Kwara

Charles A Peloquin

2024/2/11

Role of therapeutic drug monitoring in the treatment of multi-drug resistant tuberculosis

Open forum infectious diseases

En-Ling Wu

Omar Al-Heeti

Brian M Hoff

Janna L Williams

Karen M Krueger

...

2022/8/1

Isoniazid urine spectrophotometry for prediction of serum pharmacokinetics in adults with TB

IJTLD OPEN

PS Rao

K Reed

N Modi

D Handler

K Petros de Guex

...

2024/2/1

VIGAB-STAT—A Phase IIa Feasibility Trial of Irreversible GABA-transaminase Inhibition as Adjunct Treatment of Status Epilepticus After Cardiac Arrest (P4-2.003)

Bakhtawar Ahmad

Nicole Maranchick

Daniela Pomar-Forero

Katharina Busl

Lawrence Hirsch

...

2024/4/14

Association of piperacillin and vancomycin exposure on acute kidney injury during combination therapy

JAC-Antimicrobial Resistance

Veena Venugopalan

Nicole Maranchick

Devorah Hanai

Yaima Jimenez Hernandez

Yuliya Joseph

...

2024/2

Dynamic PET Reveals Compartmentalized Brain and Lung Tissue Antibiotic Exposures

Sanjay Jain

Xueyi Chen

Bhavatharini Arun

Oscar Nino Meza

Mona Sarhan

...

2024/3/21

Linezolid does not improve bactericidal activity of rifampin-containing first-line regimens in animal models of TB meningitis

International journal of antimicrobial agents

Elizabeth W Tucker

Camilo A Ruiz-Bedoya

Filipa Mota

Clara Erice

John Kim

...

2024/1/1

Therapeutic drug monitoring for isoniazid and rifampicin exposure

The International Journal of Tuberculosis and Lung Disease

CA Peloquin

2024/3/1

Experience with implementing a beta-lactam therapeutic drug monitoring service in a burn intensive care unit: a retrospective chart review

Journal of Burn Care & Research

Mohammad Alshaer

Pavel Mazirka

Gena Burch

Charles Peloquin

Zachary Drabick

...

2023/1/1

Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis

Fajri Gafar

Roeland E Wasmann

Helen M McIlleron

Rob E Aarnoutse

H Simon Schaaf

...

2023/3/1

Implementation of BPaL in the United States: Experience using a novel all-oral treatment regimen for treatment of rifampin-resistant or rifampin-intolerant TB disease

Clinical Infectious Diseases

Connie A Haley

Marcos C Schechter

David Ashkin

Charles A Peloquin

J Peter Cegielski

...

2023/5/30

Clinical standards for the management of adverse effects during treatment for TB

The International Journal of Tuberculosis and Lung Disease

KP Singh

ACC Carvalho

R Centis

GB Migliori

SG Mpagama

...

2023/7/1

Pharmacokinetics, Safety, and Tolerability of Once-Daily Darunavir With Cobicistat and Weekly Isoniazid/Rifapentine

JAIDS Journal of Acquired Immune Deficiency Syndromes

Kristina M Brooks

Alice K Pau

Doris Swaim

Haden T Bunn

Lilian Adeojo

...

2023/12/15

Implementation of bedaquiline, pretomanid, and linezolid in the United States: Experience using a novel all-oral treatment regimen for treatment of rifampin-resistant or …

Clinical Infectious Diseases

Connie A Haley

Marcos C Schechter

David Ashkin

Charles A Peloquin

J Peter Cegielski

...

2023/10/1

Simplified urine-based method to detect rifampin underexposure in adults with tuberculosis: a prospective diagnostic accuracy study

Antimicrobial agents and chemotherapy

Yingda L Xie

Nisha Modi

Deborah Handler

Sijia Yu

Prakruti Rao

...

2023/11/15

Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus

The International Journal of Tuberculosis and Lung Disease

Y Alkabab

J Warkentin

J Cummins

B Katz

BM Denison

...

2023/2/1

Reply to Upton et al

Clinical Infectious Diseases

Russell R Kempker

Maia Kipiani

Charles A Peloquin

2023/7/1

Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children

The International Journal of Tuberculosis and Lung Disease

A Kwara

H Yang

C Martyn-Dickens

A Enimil

AK Amissah

...

2023/5/1

The effect of anti-tuberculosis drug pharmacokinetics on QTc prolongation

International Journal of Antimicrobial Agents

Yutong Jin

David Benkeser

Maia Kipiani

Nicole F Maranchick

Lali Mikiashvili

...

2023/10/1

See List of Professors in Charles Peloquin University(University of Florida)